Pigmented melanoma cell migration study on murine syngeneic B16F10 melanoma cells or tissue transplantation models by Predoi, Maria-Cristina et al.
Journal of Mind and Medical Sciences
Volume 6 | Issue 2 Article 20
2019
Pigmented melanoma cell migration study on
murine syngeneic B16F10 melanoma cells or tissue
transplantation models
Maria-Cristina Predoi
Ion Mîndrilă
Sandra Alice Buteică
Ovidiu Marcel Mărginean
Bogdan Mîndrilă
See next page for additional authors
Follow this and additional works at: https://scholar.valpo.edu/jmms
Part of the Dermatology Commons, Oncology Commons, and the Pathology Commons
This Research Article is brought to you for free and open access by ValpoScholar. It has been accepted for inclusion in Journal of Mind and Medical
Sciences by an authorized administrator of ValpoScholar. For more information, please contact a ValpoScholar staff member at scholar@valpo.edu.
Recommended Citation
Predoi, Maria-Cristina; Mîndrilă, Ion; Buteică, Sandra Alice; Mărginean, Ovidiu Marcel; Mîndrilă, Bogdan; and Niculescu, Mihaela
(2019) "Pigmented melanoma cell migration study on murine syngeneic B16F10 melanoma cells or tissue transplantation models,"
Journal of Mind and Medical Sciences: Vol. 6 : Iss. 2 , Article 20.
DOI: 10.22543/7674.62.P327333
Available at: https://scholar.valpo.edu/jmms/vol6/iss2/20
Pigmented melanoma cell migration study on murine syngeneic B16F10
melanoma cells or tissue transplantation models
Authors
Maria-Cristina Predoi, Ion Mîndrilă, Sandra Alice Buteică, Ovidiu Marcel Mărginean, Bogdan Mîndrilă, and
Mihaela Niculescu
This research article is available in Journal of Mind and Medical Sciences: https://scholar.valpo.edu/jmms/vol6/iss2/20
 
   
 
 
*Corresponding author: Mîndrilă Ion, Craiova University of Medicine and Pharmacy, Department of 
Morphological Sciences, Petru Rares 2, 200349, Craiova, Romania   
E-mail: tutu0101@yahoo.com  
  
 
 
 
https://scholar.valpo.edu/jmms/     
https://proscholar.org/jmms/  
ISSN: 2392-7674 
J Mind Med Sci. 2019; 6(2): 327-333 
doi: 10.22543/7674.62.P327333 
 
Received for publication: March 11, 2019 
Accepted: August 29, 2019 
Research article 
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Mărginean3, Bogdan Mîndrilă3, Mihaela Niculescu3 
 1Craiova University of Medicine and Pharmacy, Department of Morphological Sciences, Craiova, Romania  
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Abstract Melanoma is a lethal form of skin cancer with poor prognosis, especially due to the early 
metastatic feature. Recent studies have shown that the melanin pigment influences the 
nanomechanical properties and, therefore, the metastatic behavior of the melanoma cells. We aimed 
to study the growth of subcutaneously transplanted syngeneic melanoma tissue in female C57BL/6 
mice harvested from a mouse with a four-week B16F10 melanoma. Also, we studied the effect of 
the melanin pigment loading on the peritumoral migratory abilities of melanoma cells. Even when 
the syngeneic transplant was different (cultured cells vs. tumor tissue), the morphological features 
and the tumor growth were similar in both groups of mice. Heavily pigmented melanoma cells had 
low migration abilities. Angiogenesis, the depigmentation phenomenon, and the cell shape changes 
were related to pigmented melanoma cell migration along the matrix collagen fibers of peritumoral 
structures: the abluminal face of the vessels (angiotropism), the endomysium, and the nerves 
(neurotropism). The replacement of the histopathological growth pattern, the absence of 
angiogenesis, and rapidly tumor-bearing emboli were correlated with amelanotic and low 
pigmented melanoma cells. This study demonstrated that syngeneic melanoma tissue 
transplantation was a viable technique, and that the melanin pigment loading level can affect the 
melanoma cell migration profile. 
Keywords  melanoma, cell migration, B16F10 melanoma cells, tissue transplantation 
Highlights ✓ The syngeneic B16F10 melanoma tissue transplantation in C57BL/6 mice was a viable 
technique for the study of melanoma cell behavior. 
✓ The melanic pigment loading level and the ability to remove the pigment seem to be 
defining elements of the migratory behavior and aggressiveness of the B16F10 melanoma 
cells. 
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Introduction 
Melanoma is an aggressive and lethal form of skin 
cancer with a poor prognosis, especially due to its 
susceptibility to early distant metastasis (1), even from 
primary non-identifiable tumors (2). Several murine 
melanoma models, including syngeneic or xenograft 
transplantation, genetically modified models, ultraviolet 
radiation, or chemically induced melanoma, have been 
developed in recent decades to study the tumor line 
selection and cancer immunology (3, 4), to elucidate the 
mechanisms of melanoma progression and metastasis (5-
8), and to design and evaluate the novel anticancer 
therapeutic agents (9-11). 
The syngeneic B16 melanoma induced in C57BL/6 
mice through intradermic, subcutaneous, intraperitoneal, 
or intravascular injection of cancer cells is the most 
commonly used model for tumor proliferation, invasion, 
and metastatic analysis (12-14).  
Murine models transplanted with B16F1 or B16F10 
melanoma cell clones provide a valuable tool for the study 
of primary tumor growth and metastatic potential to distant 
visceral organs (15, 16). Widespread metastasis is the main 
cause of death from melanoma (17), and it is associated 
with resistance to therapeutic agents and increased disease 
recurrence (18). The study of the local invasion of 
melanoma cells, the first stage of the metastatic process 
that occurs in the primary tumor (18), can be a way to better 
understand why the malignant melanoma is such an 
aggressive disease and can help design new therapeutic 
strategies, including nanotechnology (19, 20). 
Recently, several studies have shown that the 
nanomechanical phenotype of the cell can be an important 
indicator of metastatic abilities, and that cell elasticity may 
play a key role in determining the invasive potential of 
cancer cells (21-23). Thus, the presence of the melanin 
pigment altered the elastic properties of the cells and 
reduced the cell migration capabilities of the melanoma 
cells (24).  
In this work, we aimed to study the development of the 
melanoma tumor obtained through the subcutaneous 
transplantation of syngeneic melanoma tissue, and also the 
influence of melanin pigment loading on the metastatic 
migratory abilities of the melanoma cell. We used the 
syngeneic model of melanoma obtained in two groups of 
C57BL/6 mice using two different transplantation 
techniques: one group was subcutaneously injected with 
B16F10 cultured melanoma cells, and the other group was 
subcutaneously injected with melanoma tumor tissues 
harvested from a randomly selected 4-week tumor 
developed in the first group of mice.  
Materials and Methods 
Cell culture 
For this study, we used the B16F10 mouse melanoma 
cell line obtained from The Institute of Biology of the 
Romanian Academy. Melanoma cells were grown in 
Dulbecco’s Modified Eagle Medium® supplemented with 
10% fetal bovine serum and antibiotics (1ooU/ml penicillin 
and streptomycin) and maintained at 37°C in a humidified 
atmosphere with 5% CO2. The B16F10 cells were 
harvested from culture during the logarithmic growth 
phase (flasks should be ≤50% confluent) by trypsinization, 
washed and re-suspended in cold saline. The viable cells 
were counted by using trypan blue exclusion and finally the 
cell concentration was adjusted to 1x106 cells/mL. 
Murine model 
Experiments on animals were carried out after the 
approval of the Committee of Ethics and Scientific 
Deontology of the University of Medicine and Pharmacy 
of Craiova. Female C57BL/6 mice (n=19) obtained from 
the Animal Facility of the University (aged 8 weeks, 
weighing between 17g and 22 g) were used. The mice were 
housed in stainless steel cages at 21°C under a 12:12 light-
dark cycle and had free access to standard laboratory chow 
and water.  
Under Ketamine (100 mg/Kg) and Xylazine (10 
mg/Kg) anesthesia, a first group of 9 mice were injected 
subcutaneously into previously shaved left lateral flank 
with 0.2 ml of saline melanoma B16F10 cell suspension (2 
x 105 cells) using a 22G needle. The mice were monitored 
twice a week for 6 weeks to assess the local tumor growth 
by ultrasonography and measurement of the tumor 
diameter using a caliper. The tumor volume was calculated 
as 0.52 x (long diameter) x (short diameter) 2 (25). Three 
randomly selected mice were sacrificed through 
intraperitoneal administration of pentobarbital at a dose of 
120 mg/Kg at an interval of 2, 4, and 6 weeks after the 
initial inoculation with B16F10 melanoma cells.  
Before the sacrifice, one of the randomly selected mice 
with a 4-week old tumor was anesthetized with 
Ketamine/Xylazine and used for harvesting malignant 
melanoma tissue with an 18G needle assembled onto a 10 
mL syringe. With the tip of the needle inserted into the 
tumor and the full retraction of the plunger of the syringe 
to generate vacuum, 1mL tumor tissue was harvested by 
maneuvering the needle back and forth in various 
directions into the tumor mass without letting the needle 
come out of the skin. After suction, 1.5 mL of saline 
solution was added and the syringe content was firmly 
agitated. 
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A second group of female C57BL/6 mice (n=10) were 
each injected with a 0.2 mL melanoma tissue suspension 
using the same protocol described above. This group was 
monitored for 6 weeks after which the mice were sacrificed 
through the intraperitoneal administration of pentobarbital. 
For each sacrificed mouse, autopsy was performed to 
assess primary tumor extension and distant metastasis. 
Primary tumor and surrounding tissue were harvested for 
histological studies. 
Histopathology 
Formalin fixed samples were processed for paraffin 
embedding through standard methods, cut into 6 µm thick 
sections, and stained with Hematoxylin & Eosin and azan 
trichrome for the light microscopic examination. 
Results 
All mice inoculated with B16F10 cells developed 
tumors at the site of the implant. One mouse failed to 
develop a tumor at the implant site (figure 1b), and one 
tumor stopped growing after a week (figure 1c) in the 
group inoculated with tumor tissue. In the first group of 
mice, tumors showed exponential growth, becoming 
palpable after 6 days and then doubling in bulk weekly to 
reach an average volume of 15.28 ± 3.68 cm3 at 6 weeks.  
 
Figure 1. Growth assessment of syngeneic B16F10 
melanoma cells or tissue transplanted into C57BL/6 
mice (a). The implant site of non-developed tissue 
melanoma (b) and growth stopped melanoma (c). 
Six-week cells (d) and tissue (e) implanted 
melanoma. Bares = 1 mm. 
Tumors of the second group of mice also had an 
exponential evolution, although the mean tumor volume at 
6 weeks was smaller than the first group, subsequently 
reaching the value of 10.37 ± 0.85 cm3 (figure 1 a). The 
necrotic lesions of the skin overlying the implant site were 
observed in mice with tumors older than 5 weeks. Similar 
macroscopic aspects of tumors in both studied groups were 
revealed at autopsy (Figure 1 d, e). 
The migration of pigmented melanoma cells through 
the connective tissue 
Several migration patterns of pigmented melanoma 
cells were identified in the peritumoral connective tissue 
and the muscles around the primary tumor. Changes in the 
shape and stiffness of the pigmented melanoma cells due 
to the interaction with the surrounding stromal elements 
can be observed during migration through the connective 
tissue. These changes in cell morphology are associated 
with a decrease in the pigment loading of melanoma cells. 
Individual low-pigmented melanoma cells with fibroblast-
like spindle-shaped morphology and extension of the cell's 
leading edge attached to the matrix fibers of connective 
tissue were identified at a distance from the primary tumor. 
These so-called “path-generating cells” set the direction of 
migration and are followed by clusters of interconnected 
melanoma cells (Figure 2 a, b). 
 
Figure 2. Cluster of migratory pigmented 
melanoma cells (a, b), and melanoma cell shape and 
pigment loading level changes (c-g) during 
peritumoral connective tissue migration. H&E (a-c, 
e, f) and azan trichrome (d, g) staining. Bare = 100 
(a); 25 (b, c, d); 10 (e, f, g) µm. 
This is a way for pigmented cells to invade muscles that 
do not have direct contact with the primary tumor. Once 
these cells have set the migration route, a large number of 
pigment-loaded melanoma cells leave the primary tumor, 
undergo changes in shape and pigment content, and 
migrate through the peritumoral connective tissue to 
invade the distant muscle structure (Figure 2 c-g). 
Maria-Cristina Predoi et al. 
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Increased vascularity with large newly-formed perimysial 
vessels that dissociate muscle bundles were identified in 
the invasion front of the muscle by migratory melanoma 
cells (Figure 2 d). Only amelanic or low-level pigmented 
melanoma cells were identified in the lumen of these newly 
formed vessels (Figure 2 g). 
The migration of pigmented melanoma cells through 
the muscle 
Other patterns of migration related to the absence or 
presence of desmoplastic reaction in the invasion front 
(Figure 3 a, b) were also observed when the pigmented 
melanoma cells invade muscle bundles in direct contact 
with the primary tumor. 
The newly formed perimysial and endomysial 
capillaries that dissociate the muscle fibers are used by 
chains or clusters of pigmented melanoma cells as an entry 
route when there is no desmoplastic reaction in the tumor-
muscle interface (Figure 3 c, d).  
Both “individual cell migration” and “collective 
migration” patterns were detected during the endomysial 
fibrous connective infiltration by the pigmented tumor 
cells. As the pigmented cells migrate, a depigmentation 
process takes place and the initial round cells become 
elongated (Figure 3 f). Chains or single melanoma cells 
with progressive depigmentation levels attached to the 
abluminal surface of vessels (angiotropism), the 
endomysium of muscle fibers (myotropism) or nerve fibers 
(neurotropism) could be highlighted in the tumor 
infiltrating muscle, away from the invasion front (Figure 3 
e, f, h). 
Areas with thickening and fibro sclerosis of the muscle 
perimysium containing fibroblast-like poorly loaded 
melanin pigment tumor cells were identified in the muscle-
tumor contact sites with desmoplastic reaction. This fibro 
sclerotic reaction appears to prevent the infiltration of the 
muscle by the melanoma tumor cells and can be considered 
a barrier in front of the tumor invasion. However, fine 
networks of newly formed vessels could be identified on 
both sides of this fibro sclerotic barrier both in the 
desmoplastic tissue and the adjacent muscle fiber 
endomysium. Pigmented melanoma cells that migrate 
through the desmoplastic tissue undergo rapid 
depigmentation and fibroblast-like transformation. Cell 
groups formed by three depigmented melanoma cells 
flanked by a fibroblast were observed frequently during 
migration through desmoplastic tissue (Figure 3 g). No 
pigmented cell was observed in the lumen of the 
desmoplastic tissue vessels. 
The migration of low-pigmented and amelanic 
melanoma cells through the muscle 
The replacement histopathological growth pattern was 
specific to muscle invasion by this type of melanoma cells 
(Figure 4 a). 
 
Figure 4. The avascular infiltrative histopathological 
growth pattern of amelanotic and the low pigmented 
melanoma cells with progressive replacement of 
muscle fibers (a), extensive tumor necrosis and the 
occurrence of blood lacunae delimited by melanoma 
cells (b). The peripheral arrangement of heavily 
pigmented melanoma cells (c) and the invasion of the 
nearby muscle in the tumor with the stopped growth 
(d). Azan trichrome (a, b) and H&E (c, d) staining. Bare 
= 100 (a, b); 10 (c, d) µm. 
 
Figure 3. Interfaces of pigmented melanoma cell 
muscle migration with angiogenesis (a-white arrows), 
or desmoplastic reaction with strips of dense collagen 
(b-white arrowheads) that separates the muscle from 
the tumor. The migration patterns of the pigmented 
melanoma cells through muscle tissue: cluster of cells 
(c); Indian file pattern (d); neurotropism (e); 
endomysial (myotropism) (f); and angiotropism (h). 
Pack of fibroblast (black arrow) and depigmented 
melanoma cells (black arrowheads) in the desmoplastic 
area (g). Azan trichrome staining. Bare = 100 µm (a, b); 
10 µm (c- h). 
Pigmented melanoma cell migration 
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The infiltration, dissociation, destruction, and 
replacement of muscle fibers by cancer cells, the lack of 
angiogenesis, and the ability to generate tumor emboli by 
rapidly invading the lumen of the lymphatic and blood 
vessels are the morphological aspects common in the case 
of invasion by amelanic or low pigmented melanoma cells. 
Finally, a tumor mass with numerous areas of necrosis and 
blood lacunae delimited by tumor cells replaced the initial 
muscle tissue (Figure 4 b). 
The migration of heavily pigmented melanoma cells 
A large subpopulation of heavily pigmented cells 
disposed at the periphery of the primary tumor was 
highlighted by the histological examination of the stopped 
growth tumor (Figure 4 c). Only a few heavily pigmented 
melanoma cells that migrated attached to the vessels or 
between neighboring muscle bundles were identified 
(Figure 4 d). The wedge-like clusters of slightly deformed 
cells that dissociated muscle bundles, the lack of melanoma 
cell depigmentation and the absence of host response were 
the histological aspects that characterize melanoma cell 
migration in this tumor. 
Discussions 
This study showed that the morphological features and 
tumor growth were similar in both groups of mice, even if 
the syngeneic transplant was different (cultured cells vs. 
tumor tissue). The difference in the mean volume of the 
tumors developed in the two groups of mice can be 
attributed to the different number of cells injected to 
produce the tumors, as no cell count could be made in the 
implanted tumor tissue. Unlike the allogeneic transplant 
with chemically-induced skin tumor tissues whose 
volumes started to decrease 8 days after inoculation (26), 
melanoma syngeneic transplanted tissues in mice showed 
a progressive volume increase due to the preservation of 
the tumor cell viability. This model allows the removal of 
the initial context that promotes tumor growth, created by 
the primary tumor interaction with the micro- and macro 
environment (27). Therefore, when it is necessary to assess 
the melanoma cells that have undergone behavioral 
changes by applying therapy, the syngeneic tumor tissue 
transplantation may be a viable alternative. In addition, the 
ability to study the mechanisms of transmissible cancers 
(28) can be another facility offered by this experimental 
model. 
In the case of the tumor with stopped growth, there are 
no signs of host response (replacement of melanoma cells 
with mononuclear infiltration and/or fibrosis with 
increased vascularity (29)) to consider it to be a 
histological regression. The peritumoral migration in small 
numbers of heavily pigmented melanoma cells and the 
presence of tumor emboli identified in the pulmonary 
arteries are elements that support the view that 
hyperpigmentation is likely the factor that slows tumor 
growth in this case than a sign of the spontaneous 
histological regression of the primary tumor.  
A series of recent studies has shown that the level of 
pigment loading can affect the metastatic behavior of 
melanoma cells (23, 24). Melanin pigment synthesis and 
its loading into granule-like organelles called 
melanosomes are heterogeneous processes that can lead to 
different levels of melanoma cell pigmentation (30, 31, 
32). Due to the fact that loaded melanosomes are very stiff 
and hard to deform, the elasticity of the pigmented 
melanoma cells depends solely on the amount of 
endogenous pigment (23). The cancer cells with high 
elasticity exhibited higher invasive potential (22).  
Unlike heavily pigmented melanoma cells, the other 
pigmented melanoma cells exhibit more migratory 
abilities. Environmental properties directly influence the 
morphological changes of the pigmented cells during 
migration. Progressive depigmentation appears to be a 
necessity for adapting the shape of the cell and can 
approach complete depigmentation. Moreover, changes in 
pigment production are reversible, and melanoma cells 
could increase pigmentation when they reach metastatic 
locations (24). 
The rapid depigmentation, the fibroblast-like 
transformation of melanoma cells, and the formation of cell 
groups consisting of a fibroblast and some melanoma cells, 
are morphological traits observed mainly in the melanoma 
that displays a variable pattern of desmoplasia. Melanoma–
fibroblast interactions can be considered the cause of these 
morphological changes, knowing that melanoma cells can 
recruit and activate stromal fibroblasts which in turn 
provide the structural and chemical support for melanoma 
cell migration (33, 34, 35). 
The lack of pigmented melanoma cells in the lumen of 
newly formed vessels could explain the local 
aggressiveness and low metastatic rate observed in these 
types of melanoma (36). 
Whereas low-level pigmented or amelanotic melanoma 
cells can pass directly into the lumen of the primary tumor 
lymphatic vessels, it seems that pigmented melanoma cells 
need depigmentation to pass through the wall of the blood 
vessels, the ability of the melanoma cell to pass through a 
mechanical barrier being directly influenced by the level of 
pigmentation (37). Therefore, it might be concluded that 
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one of the causes of angiotropism is the pigmented 
melanoma cells’ inability to penetrate the vascular wall. 
The invasion patterns of the muscles highlighted in the 
same tumor showed differences in the aggressiveness of 
various subpopulations of pigmented melanoma cells. 
While pigmented melanoma cells exhibited the ability to 
migrate with the induction of alterations in the muscle 
perimysium and endomysium, amelanotic and low-
pigmented melanoma cells replaced muscle fibers with 
tumor tissue and rapidly entered the lymphatic vessels. The 
modulation of the migratory abilities by the pigment 
loading level could explain the possible relationship 
between the pigmentation of the melanoma cells and the 
patient’s survival, also highlighted in a series of recent 
studies (38, 39).  
Conclusions 
This study showed that syngeneic B16F10 melanoma 
tissue transplantation in C57BL/6 mice was a viable 
technique for the study of melanoma cell behavior. The 
melanic pigment loading level and the ability to remove the 
pigment seem to be defining elements of the migratory 
behavior and aggressiveness of the B16F10 melanoma 
cells. 
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